21 on Hong'an 3rd Street, Yantian District, Shenzhen, Information Disclosure Department: Securities Department, Information Disclosure Department Tel: 0755-36307065, International Thousand Human Genome Project, Diabetes associated genes and mutation study, Chinese Thousand Monogenetic Diseases Research Program, Thousand Plant and Animal Reference Genomes Project, Thousand vertebrate genomes project (G10K), "World Three Poles" Animal Genomes Project, Metagenomics of the Human Intestinal Tract (MetHIT), Big data driven integrative cell-omics study, Oseq™ of Tumor Drug Test for Personalized Medicine, PMSeq® high-throughput genetic detection of pathogenic microorganisms, Nutritional Intervention and Drug Safety Testing, Non-invasive DNA paternity testing during pregnancy, MGISP-960 High-throughput Automated Sample Preparation System, MGISP-100 Automated Sample Preparation System, MGIUS-R3 Remote Ultrasound Diagnostic System, MGIEasy Whole Genome Bisulfite Sequencing Library Prep Kit, MGICare BRCA1/2 Sequencing Library Preparation Kit, MGICare Single Cell Chromosomal Copy Number Variation Detection Kit, MGICare Cell-Free DNA Chromosomal Aneuploidy and Single Gene Disease Sequencing Library Prep Set, MGICare Single Gene Genomic Disease Phasing and Chromosome Copy Number Variation Sequencing Library Prep Set, MGIEasy Exome Capture V5 Universal Reagent Kit, Mgieasy exome capture V4 Universal Reagent Kit. … Continue reading “BGI Genomics and Pryzm Health Form Strategic Partnership to Advance Precision Public Health”, MELBOURNE, April 30, 2019 — MGI, a division of global genomics leader BGI Group, announced that Micromon Genomics is the first Australian commercial user of its high-throughput genetic sequencer MGISEQ-2000. In April 2018, Hong Kong instituted new rules allowing biotech firms to list on the city’s exchange even if they had yet to make a profit. BGI Genomics Co., Ltd. has 3150 total employees across all of its locations and generates $398.02 million in sales (USD). Genome sequencing company BGI Genomics Co. Ltd.’s annual net profit fell for the first time since 2015 after its shares tumbled amid brewing questions about the effectiveness of its services. MELBOURNE, April 30, 2019 — MGI, a division of global genomics leader BGI Group, announced that Micromon Genomics is the first Australian commercial user of its high-throughput genetic sequencer MGISEQ-2000. BGI offers a complete line of NGS services, and the world’s broadest portfolio of Whole Genome Sequencing services including True PCR-free WGS, low-pass WGS, with prices starting from an amazing $600. Downloads. In its … In its annual report, the company noted that the public concerns sparked by the story hurt its reputation and brand image. CNGBdb information session: CNGBdb contributes to advance enterprises cancer research, 1 projects of colon cancer research about data of exome, CNGBdb Hands-on-Lab Cancer Analysis Course 04: GATK Germline Variations Analysis, Connections between the human gut microbiome and gestational diabetes mellitus, BGIGene - Popular biology research projects topics and interesting ideas. Botswana Geoscience Institute (BGI) and Botswana International University of Science and Technology... BGI & JOGMEC REMOTE SENSING SEMINAR 2018 . Investor Relations. BGI Genomics mainly provides gene researching and testing services to clients across the globe. In July, Chinese tech news site Huxiu reported that an infant in Central China’s Hunan province was born with birth defects even though BGI Genomics prenatal tests indicated little risk of genetic abnormality. BGI and BIUST Sign MOU . BGI follows a genomics development model of “production, study and research”. BGI Genomics’ stock more than doubled in the first six months after its initial public offering (IPO) in July 2017, but the market turned on it the following January as the public began questioning the effectiveness of its tests. BGI Genomics’ core fertility business generated more than half of the company’s revenue, the company’s annual report said. The biggest part of the fertility business is noninvasive prenatal testing services, in which the company uses a small amount of a pregnant woman’s DNA to screen for abnormalities in a fetus. CNGB Introduction of China National GeneBank CNGBdb Public Service Platform. We will … Continue reading “BGI at ASHG 2019, Houston”, Shenzhen, May 14, 2019 – BGI Genomics and Pryzm Health, digital health start-up, signed a Memorandum of Understanding (MoU) for collaboration to advance precision public health in Australia. WHAT IS ICG? Photo: IC Photo, China’s Largest Gene Startup Gets Green Light for Public Listing, After failed attempts to list on Nasdaq and Hong Kong exchanges, BGI Genomics receives approval for ChiNext IPO, Biotech Startup Slashes Hong Kong IPO by 23%, CStone Pharmaceuticals now aims to raise $304 million to fund development of targeted cancer drugs, Active Coronavirus Samples Found on Frozen Food Packaging for First Time, Xiaomi Shows off Super-Fast-Charging Wireless Technology, China’s 3DMed Diagnostic Raises $224m in Second Equity Financing Round, Trending in China: Bear Attack Killing Keeper Sparks Debate Over Animal Cruelty, China to Buy Two-Thirds of Global 5G Phones This Year: IDC, EV Startup Faraday Gets Financial Lifeline from U.S. Copyright © 2019 Caixin Global Limited. Updates on BGI developments in life science research, education and industry. Botswana Geoscience Institute (BGI) & Japan Oil, Gas and Metals National Corporation (JOGMEC)... BGI Bullish on Earthquake Monitoring . It debuted on the Shenzhen Stock Exchange’s Nasdaq-style ChiNext board in July 2017 in a 484 million yuan listing. Trending in China: Why Is China Getting Fit With a German Instructor? Human Gut Microbiomes Dataset: 13 projects research about data of raw sequence reads, etc. The company is one an emerging group of fast-growing biotech companies that have been tapping financial markets. Vision – To be a world leader in the age of life sciences. The company said it had done 4.3 million such tests globally by the end of 2018. BGI Genomics Co., Ltd. is located in Shenzhen, Guangdong, China and is part of the Scientific Research & Development Services Industry. CONFERENCE ANNOUNCEMENT … Continue reading “The 14th Annual Meeting of the International Conference on Genomics (ICG-14)”, We are looking forward to seeing you in Houston to discuss exiting new Genomic Solutions for your research. Some of its largest clients include state-owned China National Tobacco Corp. and the University of Oxford. The biggest part of the fertility business is noninvasive prenatal testing services, in which the company uses a small amount of a pregnant woman’s DNA to screen for abnormalities in a fetus. Core Values – Curiosity, Application of Knowledge, Working for the Betterment of Mankind. Source: BGI Annual Report 2019. Contact reporter Tang Ziyi (ziyitang@caixin.com). In January 2018, BGI Genomics CEO, Yin Ye, stated they sequenced over 10,000 WGS samples, with additional 20,000 being sequenced by their BGISEQ-500 platform, about 70% of animals and plants until now were sequenced by the company and their partners, as well worked on … All Rights Reserved. The Shenzhen-listed company Wednesday reported its net profit fell 2.9% to 387 million yuan ($57.62 million) last year due to rising costs for sales and technology development, as revenue rose 21% to 2.5 billion yuan. CNGB. Recognizes Hero Who Fought High Food Prices at Ground Zero of the Pandemic. Get the detailed quarterly/annual income statement for BGI GENOMICS CO LT (300676.SZ). 3 projects of colorectal cancer research about data of transcriptome, gene expression, exome, etc. Find out the revenue, expenses and profit or loss over the last fiscal year. BGI Genomics (Abbreviation: "BGI", stock code 300676), Address: 7th-14thFloor, Building 7, BGI Comprehensive Park, No. Since listing, however, some of these companies have suffered sharp drops in their stock prices due to vaccine scandals and the government’s push to lower drug prices. Merchant Bank, Tencent Chooses Co-Working Space For First Singapore Office, Trending in China: U.N. Researchers operate a gene sequencing machine in Qingdao, East China's Shandong province on May 29, 2018. Monash University’s Micromon Genomics, a next-generation sequencing facility located in the university’s Biomedical precinct at the Clayton campus in Melbourne, provides sequencing services to Australian … Continue reading “Australia’s First Commercial MGISEQ-2000 Genetic Sequencer Now in Operation”, April 30, 2019 – In a major breakthrough, scientists from 21 global research institutes have successfully completed sequencing of 429 chickpea lines from 45 countries to identify genes for tolerance to drought and heat. BGI ANNUAL REPORT 201700.pdf. Annual Report 2017. It takes place annually in the last week of October, uniting 1,000+ attendees and sharing with the best minds in ‘omics’ and its application from institutions all over the world. Mission – Trans-omics for a better life. With branches in more than 100 countries and regions around the world, BGI has established cooperation and partnerships with thousands of different organizations across multi-disciplinary research areas including medical health, resource conservation and judicial services. The company has also established China’s first national gene bank, which opened in 2016. BGI Genomics’ core fertility business generated more than half of the company’s revenue, the company’s annual report said. Stock analysis for BGI Genomics Co Ltd (300676:Shenzhen) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Scientific BGI Platform BGI Science Research Institute Research Results Research Publication Technology Human Disease Plant and Animal Microbial Sequencing Diagnostics Clinical Diagnosis IVD Test Forensics Instrument Platform NGS Platforms Reagents Solutions About BGI Introduction News Media Investor CNGB Introduction CNGBdb Public Service … Home; Group station; Contact us; Tel：+86-755-36307888 Fax：+86-755-36307273 Service Email：info@genomics.cn Media contact：media@genomics.cn Address：Building 11, Beishan Industrial Zone, Yantian District, Shenzhen（518083） Investor Relations. Since its inauguration in 2006, ICG has established itself as a premier conference featuring cutting-edge omics technologies and sharing of ideas. With their complementary expertise and technology, BGI Genomics and Pryzm Health will develop foundational capabilities to drive equitable access to precision medicine approaches across the health system.